Maruho Co. Ltd.
Latest From Maruho Co. Ltd.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.
Derma specialist Maruho has taken steps to recharge its pipeline through deals with fellow Japanese firms for two novel assets.
- Topical Delivery
- Drug Delivery
- Therapeutic Areas
- Pacific Rim
- Parent & Subsidiaries
- Maruho Co. Ltd.
- Senior Management
Koichi Takagi, Pres.
Takahide Kitada , Corp. Officer, Strategies & Licensing
Yasuhiko Kito, Sr. Corp. Officer, Bus. Operations
Hidehiko Atago, Corp. Officer, Clinical Dev. & R&D Admin.
Masahiro Akatsuka , Corp. Officer, Research
Takashi Kitagawa, Corp. Officer, Mktg., Sales Admin. & Dist.
- Contact Info
Maruho Co. Ltd.
Phone: (81) 63 718 876
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.